Wikipedia -WSS

Wikipedia

author：fashion 2025-09-06 04:51:36 - browse：1825

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Virtual care provider acquires bankrupt Pear's prescription apps

WSS

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Christmas in the PICU brings some surprising joy

New study raises questions about niacin and heart health

Ukraine seeks to reclaim its role as a hub for clinical trials

David Ricks of Eli Lilly: best biopharma CEO of 2023

How to keep neuroscience’s past racism from being its future

knowledge

Wikipedia

focus

Activists slam private health insurers over coverage restrictions

Researchers tackle phage therapy hurdles for wider adoption

Hollywood unions extend contract negotiations for actors

Medicare drug price negotiation hasn't dried up venture capital

Medical records are filled with copy

What STAT readers think about the FDA and patient advocacy

Hollywood unions extend contract negotiations for actors

CRISPR gene editing developments we’re watching in 2024

At least 13 dead in Texas as scorching temps continue

WATCH: Why do our ears pop?

leisure time

A new drug could help frostbite victims avoid its ravages

HCA sued by state AG for quality issues at Mission Health

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Weight loss drugs aren’t covered by Obamacare. That may change

Hospitals are piloting generative AI tools as regulators play catch

focus

focus

Wikipedia

entertainment